copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
About Lyme Disease | Lyme Disease | CDC Lyme disease is a bacterial infection spread to people through the bite of blacklegged ticks Typical symptoms include fever, headache, fatigue, and a characteristic skin rash called erythema migrans
Lyme Disease | Lyme Disease | CDC About Lyme Disease General information on Lyme disease including prevention and what to do after a tick bite
Signs and Symptoms of Untreated Lyme Disease Untreated Lyme disease can produce a wide range of symptoms, depending on the stage of infection These include fever, rash, facial paralysis, an irregular heartbeat, and arthritis
Testing and Diagnosis for Lyme disease | Lyme Disease | CDC Healthcare providers consider multiple factors when evaluating a patient for Lyme disease Laboratory diagnosis of Lyme disease relies on a blood test that detects antibodies to the Lyme bacteria
How Lyme Disease Spreads | Lyme Disease | CDC The bacteria that cause Lyme disease in the United States, Borrelia burgdorferi and, rarely, B mayonii, are spread to people through the bites of infected ticks
Chronic Symptoms and Lyme Disease | Lyme Disease | CDC Lyme disease is an illness caused by the bacteria Borrelia burgdorferi and spread by blacklegged ticks Although most people recover completely when treated with a 2- to 4-week course of oral antibiotics, some can have prolonged symptoms of fatigue, body aches, or difficulty thinking
Clinical Care and Treatment of Lyme Arthritis | Lyme Disease | CDC Lyme arthritis occurs when Lyme disease bacteria enter joint tissue and cause inflammation People who do not receive prompt treatment for Lyme arthritis are at risk of developing permanent joint damage
Lyme Disease Vaccine | Lyme Disease | CDC Clinical trials of new vaccines for Lyme disease are currently underway Valneva and Pfizer have developed a Lyme disease vaccine candidate, VLA15, that is currently in Phase 3 human trials